Ellagic Acid Enhances Apoptotic Sensitivity of Breast Cancer Cells to γ-Radiation

References

• Siegel R, Naishadham D, and Jemal A: Cancer statistics. CA Cancer J Clin 63(1), 11–30, 2013.
   PubMed Web of Science ®Google Scholar
• Kumar B, Joshi J, Kumar A, Pandey BN, Hazra B, et al.: Radiosensitization by diospyrin diethylether in MCF-7 breast carcinoma cell line. Mol Cell Biochem 304(1–2), 287–296. 2007.
   PubMed Web of Science ®Google Scholar
• Sandhya T, and Mishra KP: Cytotoxic response of breast cancer cell lines, MCF 7 and T 47 D to triphala and its modification by antioxidants. Cancer Lett 238(2), 304–313, 2006.
   PubMed Web of Science ®Google Scholar
• Ahire V, Mishra KP, and Kulkarni GR: On the mechanism of cellular toxicity in breast cancer by ionizing radiation and chemotherapeutic drugs. J Environ Pathol Toxicol Oncol 33(1), 69–82, 2014.
   PubMed Web of Science ®Google Scholar
• Kumar B, Kumar A, Pandey BN, Mishra KP, and Hazra B: Role of mitochondrial oxidative stress in the apoptosis induced by diospyrin diethylether in human breast carcinoma (MCF-7) cells. Mol Cell Biochem 320(1–2), 185–195, 2009.
   PubMed Web of Science ®Google Scholar
• Deeb D, Yong X, Hao XU, Xiaohua J, Gao X, et al.: Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing lignad-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2, 95–103, 2003.
   PubMed Web of Science ®Google Scholar
• Urtasun RC: Chemical modifiers of radiation. In: Text Book of Radiation Oncology, Lieberl SA and Phillips TL (eds.). Philadelphia, PA: WB Saunders Company, 1998, pp. 42–52.
   Google Scholar
• Bump EA, Hoffman SJ, and Foye WO: Radiosensitizers and radioprotective agents. In: Burger's Medicinal Chemistry and Drug Discovery, Vol. 5: Chemotherapeutic Drugs. Abraham DJ (ed.). John Wiley, 2003.
   Google Scholar
• Stenzel RA, Rajesh D, and Howard SP: Flavopiridol as a radiosensitizer in malignant glimoas. Proc Am Assoc Cancer Res 43, A975, 2002.
   Google Scholar
• Xu L, Yang D, Wang S, Tang W, Liu M, et al.: (−)-Gossypol enhances response to radiotherapy and results in tumour regression of human prostate cancer. Mol Cancer Ther 4(2), 197–205, 2005.
   PubMed Web of Science ®Google Scholar
• Kumar B, Joshi J, Kumar A, Pandey BN, Hazra B, et al.: Radiosensitization by diosypyrin diethylether in MCF-7 breast carcinoma cell line. Mol Cell Biochem 304(1–2), 287–296, 2007.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Sakr WA, and Wahidur Rahman K: Anticancer properties of indole compounds: Mechanism of apoptosis induction and role in chemotherapy. Curr Drug Targets 11(6), 652–666, 2010.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Sakr WA, and Rahman KW: Mechanisms and therapeutic implications of cell death induction by indole compounds. Cancers (Basel) 3(3), 2955–2974, 2011.
   PubMedGoogle Scholar
• Ahmad A, Padhye S, and Sarkar FH: Role of novel nutraceuticals Garcinol, Plumbagin and Mangiferin in the prevention and therapy of human malignancies: mechanisms of anticancer activity. In: Nutraceuticals and Cancer, Sarkar FH (ed.). New York, NY: Springer, 2012, pp. 179–199.
   Google Scholar
• Sarkar FH, Li Y, Wang Z, and Kong D: The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev 29(3), 383–394, 2010.
   PubMed Web of Science ®Google Scholar
• Bhosle SM, Ahire VR, Henry MS, Thakur VS, Huilgol NG, et al.: Augmentation of radiation-induced apoptosis by ellagic acid. Cancer Invest 28(3), 323–330, 2010.
   PubMed Web of Science ®Google Scholar
• Li Y, Wicha MS, Schwartz SJ, and Sun D: Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J Nutr Biochem 22(9), 799–806, 2011.
   PubMed Web of Science ®Google Scholar
• Papoutsi Z, Kassi E, Tsiapara A, Fokialakis N, Chrousos GP, et al.: Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta. J Agric Food Chem 53(20), 7715–7720, 2005.
   PubMed Web of Science ®Google Scholar
• Mertens-Talcott SU, Bomser JA, Romero C, Talcott ST, and Percival SS: Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53, and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J Nutr 135(3), 609–614, 2005.
   PubMed Web of Science ®Google Scholar
• Mertens-Talcott SU, and Percival SS: Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218(2), 141–151, 2005.
   PubMed Web of Science ®Google Scholar
• Bhosle SM, Huilgol NG, and Mishra KP: Enhancement of radiation-induced oxidative stress and cytotoxicity in tumor cells by ellagic acid. Clin Chim Acta 359(1–2), 89–100, 2005.
   PubMed Web of Science ®Google Scholar
• Mishra K, Girdhani S, Bhosle S, Thulsidas S, and Kumar A: Potential of radiosensitizing agents in cancer chemo-radiotherapy. J Cancer Res Ther 1(3), 129, 2005.
   PubMedGoogle Scholar
• Ahire VR, Mishra KP, and Kulkarni GR: Apoptotic radiosensitivity of cervical tumor cells enhanced by ellagic acid. Eur J Biotechnol Biosci 3(4), 56–58, 2015.
   Google Scholar
• Ahire VR, Mishra KP, and Kulkarni GR: Ellagic acid: A potent radio-sensitizer in cancer radiotherapy. Cancer Res Front 2(2), 141–155, 2016.
   Google Scholar
• Li T-M, Chen G-W, Su C-C, Lin J-G, Yeh C-C, et al.: Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 25(2A), 971–979, 2005.
   PubMed Web of Science ®Google Scholar
• Luzhna L, Golubov A, Ilnytskyy S, Chekhun VF, and Kovalchuk O: Molecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells. Int J Oncol 42(5), 1692–1708, 2013.
   PubMed Web of Science ®Google Scholar